Pathogenic processes
| * | Process | Total | Neutral | Plus | Minus |
|---|---|---|---|---|---|
| * | Process | Total | Neutral | Plus | Minus |
 | Invasion | 12 | 1 | 3 | 8 |
| Metastasis | 6 | 1 | 2 | 3 |
migration | 10 | 0 | 5 | 5 | |
Apoptosis | 16 | 3 | 5 | 8 | |
motility | 5 | 1 | 3 | 1 | |
 | Cell growth | 6 | 0 | 2 | 4 |
cell viability | 4 | 0 | 2 | 2 | |
stemness | 1 | 1 | 0 | 0 | |
 | Angiogenesis | 2 | 0 | 1 | 1 |
Hypoxic response | 2 | 1 | 1 | 0 | |
 | EMT | 3 | 0 | 2 | 1 |
Autophagy | 7 | 2 | 2 | 3 | |
 | cisplatin resistance | 3 | 2 | 1 | 0 |
| gemcitabine resistance | 1 | 0 | 1 | 0 |
| growth | 1 | 1 | 0 | 0 |
Adriamycin (Adr) resistance | 1 | 0 | 0 | 1 | |
cell cycle | 2 | 0 | 1 | 1 | |
cell cycle progression | 1 | 1 | 0 | 0 | |
| AKT signaling | 2 | 0 | 2 | 0 |
| Paclitaxel resistance | 2 | 0 | 1 | 1 |
Chemoresistance | 3 | 0 | 3 | 0 | |
| Oxaliplatin resistance | 1 | 0 | 1 | 0 |
| 5fluorouracil resistance | 1 | 0 | 1 | 0 |
colony formation | 2 | 0 | 2 | 0 | |
Radioresistance | 1 | 0 | 0 | 1 | |
T cell activation | 1 | 1 | 0 | 0 | |
BRAFi resistance | 1 | 0 | 0 | 1 | |
MEKi resistance | 1 | 0 | 0 | 1 | |
| Sorafenib resistance | 1 | 0 | 1 | 0 |
adhesion | 2 | 0 | 0 | 2 | |
| tumor growth | 2 | 0 | 0 | 2 |
TRAIL resistance | 1 | 0 | 1 | 0 | |
  | Proliferation | 15 | 2 | 9 | 4 |
Showing 1 to 33 of 33 entries
No expression data
No BM data
No disease data